Junshi Biosciences Announces Collaboration with Dr. Reddy's

SHANGHAI, China, May 07, 2023 -- Shanghai Junshi Biosciences Co., Ltd announced a collaboration with Dr. Reddy’s Laboratories Limited to develop and commercialize toripalimab, the anti-PD-1... | May 7, 2023

Related Keywords

Uzbekistan , Uruguay , Panama , Beijing , China , United Kingdom , Colombia , Suzhou , Jiangsu , Bombay , Maharashtra , India , New Zealand , South Africa , Argentina , Peru , Shanghai , Australia , Brazil , Hyderabad , Andhra Pradesh , Maryland , United States , Mexico , Chile , San Francisco , California , Guangzhou , Guangdong , Chinese , America , Zhi Li , Junshi Biosciences , Junshi Bioscience , National Stock Exchange Of India , York Stock Exchange , Good Health Cant Wait , Ir Team , National Reimbursement Drug List , Bombay Stock Exchange , Pr Team , New York Stock Exchange , Regulatory Agency , Shanghai Junshi Biosciences Co Ltd , Drug Administration , European Medicines Agency , Reddy Laboratories Limited Dr , Laboratories Limited , Latin America , For Global , Chief Executive Officer , Branded Markets , Emerging Markets , Southeast Asia , Biologics License Application , Breakthrough Therapy , Fast Track , Orphan Drug , National Stock Exchange , Sustainability Report , Emergency Use Authorizations , Shanghai Junshi Biosciences Co , Td Stock Exchange , News , Information , Press Release , Bay , 023 , Junshi , Iosciences , Td , Nnounced , Collaboration , Ith , Laboratories , Imited , O , Evelop , End , Ommercialize , He 1877 Cne100003ff7 ,